HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Type 3 Congenital Generalized Lipodystrophy

Also Known As:
Lipodystrophy, Congenital Generalized, Type 3; Berardinelli-Seip Congenital Lipodystrophy, Type 3; Bscl3; Cgl3; Lipodystrophy, Berardinelli-Seip Congenital, Type 3
Networked: 5 relevant articles (0 outcomes, 0 trials/studies)

Disease Context: Research Results

Related Diseases

1. Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy)

Experts

1. Aebi, Markus: 2 articles (08/2015 - 05/2008)
2. Künzler, Markus: 2 articles (08/2015 - 05/2008)
3. Cui, Lihua: 1 article (07/2019)
4. Dai, Xide: 1 article (07/2019)
5. Huang, Zhujian: 1 article (07/2019)
6. Liu, Junhong: 1 article (07/2019)
7. Wu, Siying: 1 article (07/2019)
8. Ye, Jiaer: 1 article (07/2019)
9. Zhang, Li: 1 article (07/2019)
10. Bleuler-Martinez, Silvia: 1 article (08/2015)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Type 3 Congenital Generalized Lipodystrophy:
1. LectinsIBA
2. Proteins (Proteins, Gene)FDA Link
3. Caveolin 1IBA
4. Galectins (Galectin)IBA
5. Transcription Factor AP-1 (Transcription Factor AP 1)IBA
6. Polysaccharides (Glycans)IBA
7. CarbohydratesIBA
8. AgglutininsIBA
9. N- acetylgalactosaminyl- 1- 4- N- acetylglucosamineIBA
10. chromium hexavalent ionIBA